KRMD (KORU Medical Systems) Cyclically Adjusted PB Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KRMD KORU Medical Systems Inc KRMD
81 GF Score
Price $3.55
GF Value $4.00
Valuation Modestly Undervalued
View Full Analysis

What is KORU Medical Systems Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


KORU Medical Systems  (NAS:KRMD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


KORU Medical Systems Cyclically Adjusted PB Ratio Related Terms


KORU Medical Systems Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for KORU Medical Systems's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KORU Medical Systems Cyclically Adjusted PB Ratio Chart

KORU Medical Systems Annual Data
Trend Feb16 Feb17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.28 8.82 5.33 7.78 11.14

KORU Medical Systems Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.99 7.38 11.14 8.09 7.73

KRMD vs PDEX, EMBC, UTMD: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, KORU Medical Systems's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KORU Medical Systems Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, KORU Medical Systems's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where KORU Medical Systems's Cyclically Adjusted PB Ratio falls into.


KRMD
81GF Score
KORU Medical Systems Inc KRMD
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KORU Medical Systems Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

KORU Medical Systems's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, KORU Medical Systems's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.365/333.9520*333.9520
=0.365

Current CPI (Jun. 2026) = 333.9520.

KORU Medical Systems Quarterly Data

Book Value per Share CPI Adj_Book
201605 0.183 240.229 0.254
201608 0.180 240.849 0.250
201611 0.178 241.353 0.246
201702 0.177 243.603 0.243
201706 0.186 244.955 0.254
201709 0.193 246.819 0.261
201803 0.214 249.554 0.286
201806 0.228 251.989 0.302
201809 0.239 252.439 0.316
201812 0.235 251.233 0.312
201903 0.240 254.202 0.315
201906 0.248 256.143 0.323
201909 0.279 256.759 0.363
201912 0.284 256.974 0.369
202003 0.306 258.115 0.396
202006 0.894 257.797 1.158
202009 0.909 260.280 1.166
202012 0.836 260.474 1.072
202103 0.850 264.877 1.072
202106 0.838 271.696 1.030
202109 0.827 274.310 1.007
202112 0.818 278.802 0.980
202203 0.779 287.504 0.905
202206 0.725 296.311 0.817
202209 0.718 296.808 0.808
202212 0.689 296.797 0.775
202303 0.654 301.836 0.724
202306 0.616 305.109 0.674
202309 0.601 307.789 0.652
202312 0.446 306.746 0.486
202403 0.418 312.332 0.447
202406 0.408 314.175 0.434
202409 0.387 315.301 0.410
202412 0.366 315.605 0.387
202503 0.354 319.799 0.370
202506 0.357 322.561 0.370
202509 0.356 324.800 0.366
202512 0.368 324.054 0.379
202603 0.367 330.213 0.371
202606 0.365 333.952 0.365

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is KORU Medical Systems (KRMD) Overvalued in 2026?

Based on GuruFocus' analysis, KORU Medical Systems stock appears to be undervalued. The current stock price of $3.55 is trading 11.3% below its estimated GF Value™ of $4.00. GuruFocus considers KORU Medical Systems to be Modestly Undervalued.

Key valuation signals for KRMD:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $4.00 vs. price of $3.55 (11.3% below fair value)
  • GF Score™: 81/100

No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


KORU Medical Systems Business Description

Address 100 Corporate Drive, Mahwah, NJ, USA, 07430
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
81GF Score

Get the complete analysis for KRMD

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.55
Price
$4.00
GF Value